Cargando…
Sustained prothrombotic changes in COVID-19 patients 4 months after hospital discharge
Autores principales: | von Meijenfeldt, Fien A., Havervall, Sebastian, Adelmeijer, Jelle, Lundström, Annika, Magnusson, Maria, Mackman, Nigel, Thalin, Charlotte, Lisman, Ton |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857699/ https://www.ncbi.nlm.nih.gov/pubmed/33560386 http://dx.doi.org/10.1182/bloodadvances.2020003968 |
Ejemplares similares
-
Prothrombotic changes in patients with COVID‐19 are associated with disease severity and mortality
por: von Meijenfeldt, Fien A., et al.
Publicado: (2020) -
Elevated factor V activity and antigen levels in patients with Covid‐19 are related to disease severity and 30‐day mortality
por: von Meijenfeldt, Fien A., et al.
Publicado: (2021) -
Sustained prothrombotic changes in convalescent patients with COVID-19
por: von Meijenfeldt, Fien A, et al.
Publicado: (2021) -
Soluble angiotensin‐converting enzyme 2 is transiently elevated in COVID‐19 and correlates with specific inflammatory and endothelial markers
por: Lundström, Annika, et al.
Publicado: (2021) -
Prophylactic fresh frozen plasma and platelet transfusion have a prothrombotic effect in patients with liver disease
por: von Meijenfeldt, Fien A., et al.
Publicado: (2020)